Interleukin-1 or tumor necrosis factor-alpha augmented the cytotoxic effect of mycobacteria on human fibroblasts: Application to evaluation of pathogenesis of clinical isolates of Mycobacterium tuberculosis and M-avium complex
T. Takii et al., Interleukin-1 or tumor necrosis factor-alpha augmented the cytotoxic effect of mycobacteria on human fibroblasts: Application to evaluation of pathogenesis of clinical isolates of Mycobacterium tuberculosis and M-avium complex, J INTERF CY, 21(3), 2001, pp. 187-196
Mycobacteria-induced in vitro events reflecting human tuberculosis can cont
ribute to the evaluation of the pathogenesis of Mycobacterium tuberculosis
(MTB), In this study, we propose such an in vitro method based on live myco
bacteria-induced cytotoxicity to human cell lines. When human lung-derived
normal fibroblast cell line MRC-5 was infected with various strains of myco
bacteria (M, tuberculosis H(37)Rv and H-37 Ra, Mycobacterium avium 427S and
2151SmO, and Mycobacterium bovis BCG Pasteur and Tokyo), the fibroblasts w
ere killed by mycobacteria according to the degree of virulence, Other huma
n originated macrophage (U-937, THP-1), myeloid (HL-60), and epithelial car
cinoma (A549) cell lines exhibited a similar cytotoxic response to virulent
mycobacteria, MRC-5 was most susceptible to virulent mycobacteria among va
rious human cell lines examined, The cytotoxicity was enhanced by the proin
flammatory cytokines, interleukin-1 (IL-1) and tumor necrosis factor-a (TNF
-alpha), which in the absence of mycobacteria stimulate the growth of norma
l human fibroblasts, This in vitro evaluation system was applied to clinica
l isolates of drug-sensitive MTB (DS-MTB), drug-resistant MTB (DR-MTB) incl
uding multidrug-resistant (MDR-MTB), and M. avium complex (MAC), MTB strain
s (n = 24) exhibited strong cytotoxic activity, but MAC strains (n = 5) had
only weak activity, Furthermore, there was no significant difference in cy
totoxicity between DS-MTB (n = 11) and DR-MTB (n = 13), Collectively, these
results suggest that this new in vitro system is useful for evaluating the
pathogenesis of mycobacteria and that there was no difference in the patho
genesis between drug-susceptible and drug-resistant clinical isolates.